Topics


Glioblastoma | Etiopathogenesis | Metabolomics






Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Metabolomics






Dai J, Song S, Chen P, Huang Q, Duan H.
Analyzing research trends in glioblastoma metabolism: a bibliometric review.
Front Immunol. 2024 Oct 18;15:1444305. doi: 10.3389/fimmu.2024.1444305. PMID: 39493751. Bibiometric analysis. ˍ




Gao Y, Zhang M, Wang G, Lai W, Liao S, Chen Y, Ning Q, Tang S.
Metabolic cross-talk between glioblastoma and glioblastoma-associated microglia/macrophages: From basic insights to therapeutic strategies.
Crit Rev Oncol Hematol. 2025 Feb 6;208:104649. doi: 10.1016/j.critrevonc.2025.104649. PMID: 39922398. Review˰ ˍ




D'Aprile S, Denaro S, Gervasi A, Vicario N, Parenti R.
Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance.
Front Cell Dev Biol. 2025 Feb 26;13:1535073. doi: 10.3389/fcell.2025.1535073. PMID: 40078366. Review. ˍ




Behrooz AB, Latifi-Navid H, Zolfaghari N, Piroozmand S, Pour-Rashidi A, Bourbour M, Jusheghani F, Aghaei M, Azarpira N, Mollasalehi F, Alamdar S, Nasimian A, Lotfi J, Shojaei S, Nazar E, Ghavami S.
Metabolic reprogramming in glioblastoma: a rare case of recurrence to scalp metastasis.
BJC Rep. 2025 Apr 24;3(1):27. doi: 10.1038/s44276-025-00134-5. PMID: 40274950. Case report. ˍ




Costantini S, Di Gennaro E, Fanelli G, Bagnara P, Argenziano C, Maccanico C, Paggi MG, Budillon A, Abbruzzese C.
Glioblastoma metabolomics: uncovering biomarkers for diagnosis, prognosis and targeted therapy.
J Exp Clin Cancer Res. 2025 Aug 7;44(1):230. doi: 10.1186/s13046-025-03497-2. PMID: 40775789. Review. ˍ




Chung J, Saad J, Kafri A, Rossignol J, Verbrugge M, Bakke J.
Metabolism of glioblastoma: a review of metabolic adaptations and metabolic therapeutic interventions.
Front Oncol. 2025 Dec 10;15:1712576. doi: 10.3389/fonc.2025.1712576. PMID: 41450919. Review. ˍ




Wu F, Yin YY, Wang D, Pan CQ, Zhai Y, Yu MC, Wang ZL, Fan WH, Zhao Z, Li GZ, Jiang T, Zhang W.
Metabolic Profiling Defines Glioblastoma Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities.
Neuro Oncol. 2026 Jan 2:noaf294. doi: 10.1093/neuonc/noaf294. PMID: 41485080. Laboratory investigation. ˍ